A new report from Visiongain-Pre-Filled Syringes: World Market Outlook 2011-2021-predicts that the world pre-filled syringe technology revenues will reach $3.9 billion in 2015. That devices' market generated $2.7 billion (for the technology itself) in 2010.
Prefilled drug syringes are injecting devices that remove the filling step from another container before administering the injection. That drug delivery format is increasing in commercial importance with the expanding use of biological drugs and vaccines worldwide.
Expansion of the prefilled syringe market will be dependent upon developments in syringe technologies and materials. Improvements to performance, product stability, convenience of use and cost-effectiveness will stimulate increasing use of prefilled syringes and related devices this decade. Increased volume and viscosity handling capabilities and launches of devices that are easier to use are already benefiting sales of the devices and filled products.
Visiongain forecasts that the prefilled syringe technology and applications markets will expand steadily to 2021. The future of the prefilled drug industry and market appears promising, with increasing demand in many therapeutic areas.
More information on this study or Visiongain's range of analytical reports in healthcare and other industry areas can be found at the London-based business information company's website --www.visiongain.com
.
